Stay updated with breaking news from Lisah Lancaster. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SOUTH SAN FRANCISCO, Calif., May 24, 2023 -- Pliant Therapeutics, Inc. , a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of... | June 11, 2023
Bexotegrast was well tolerated up to 40 weeks of treatment with no drug-related serious adverse events Combination of bexotegrast with standard of care reduced FVC decline by 80% relative... | April 30, 2023
Bexotegrast was well tolerated up to 40 weeks of treatment with no drug-related serious adverse events Combination of bexotegrast with standard of care...
Bexotegrast was well tolerated up to 40 weeks of treatment with no drug-related serious adverse events Combination of bexotegrast with standard of care reduced FVC decline by 80% relative... | April 30, 2023
PLN-74809 demonstrated a dose-dependent treatment effect on FVC and QLF versus placebo over 12 weeks of treatmentPLN-74809 treatment effect was observed on...